| Identification | Back Directory | [Name]
5-((2,4-dimethoxynaphthalen-1-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | [CAS]
1584121-99-2 | [Synonyms]
IT901
IT 901;IT901;IT-901;1584121-99-2
5-((2,4-dimethoxynaphthalen-1-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
5-[(2,4-Dimethoxy-1-naphthalenyl)methylene]dihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione
4,6(1H,5H)-Pyrimidinedione, 5-[(2,4-dimethoxy-1-naphthalenyl)methylene]dihydro-2-thioxo- | [Molecular Formula]
C17H14N2O4S | [MDL Number]
MFCD30729129 | [MOL File]
1584121-99-2.mol | [Molecular Weight]
342.37 |
| Chemical Properties | Back Directory | [density ]
1.43±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF:33.0(Max Conc. mg/mL);96.39(Max Conc. mM)
DMSO:33.0(Max Conc. mg/mL);96.39(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:6):0.14(Max Conc. mg/mL);0.41(Max Conc. mM) | [form ]
A crystalline solid | [pka]
4.68±0.20(Predicted) | [color ]
Orange to red |
| Hazard Information | Back Directory | [Uses]
IT 901 is a bioactive naphthalenethiobarbiturate derivative that potently inhibits the NF-κB subunit c-?Rel. IT 901 also revealed antitumor properties in vitro and in vivo. | [in vivo]
IT-901 (24 mg/kg; IP; every other day for 2 weeks) has an effective treatment of acute GVHD without impairing anti-tumor activity[1].
IT-901 (12-20 mg/kg; IP) improves the PK profile by increasing T1/2 and Cmax[1].
| Animal Model: | BALB/C-Tg (NFkB-RE-luc)-Xen mice with 6-9 weeks old[1] | | Dosage: | 24 mg/kg | | Administration: | IP; every other day for 2 weeks | | Result: | Had an effective treatment of acute GVHD without impairing anti-tumor activity.
|
| [IC 50]
NF-κB: 0.1 μM (IC50); c-Rel: 3 μM (IC50) | [storage]
Store at -20°C |
|
| Company Name: |
Twochem Co.Ltd.
|
| Telephone: |
021-58111628 15800915896 |
| Website: |
cn.twochem.com |
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|